ARTICLE | Company News
BioSante, Corixa adjuvant deal
November 8, 2001 8:00 AM UTC
BTPH granted CRXA a non-exclusive license to its BioVant calcium phosphate nanoparticle (CAP) vaccine adjuvant for use with CRXA vaccines for cancer, infectious and autoimmune diseases. BTPH is eligib...